ArticlePloS one2025

Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway.

XiaoLin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.